Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CORCEPT THERAPEUTICS INC | 800,000 | reported | 28 Nov 2008 | tx 1+800,000 |
| Aptose Biosciences Inc. | 50,000 | reported | 18 Jan 2022 | tx 6+305,000 |
| NEORX CORP | 29,900 | reported | 06 Mar 2008 | tx 20+913,533 |
| CERO THERAPEUTICS HOLDINGS, INC. | 5,828 | reported | 14 Feb 2024 | tx 2+23,328 |
| Locust Walk Acquisition Corp. | 800 | reported | 13 Jun 2024 | tx 4+42,800−17,500 |
| CymaBay Therapeutics, Inc. | 0 | reported | 22 Mar 2024 | tx 20+283,460−283,460 |
| ZOGENIX, INC. | 0 | reported | 07 Mar 2022 | tx 4+42,000−42,000 |
| PhaseBio Pharmaceuticals Inc | 0 | reported | 19 May 2023 | tx 8+73,067−3,750 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2024 | GRANT_AWARD | Locust Walk Acquisition Corp. | 800 | 0.00 USD | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 67,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 25,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 30,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 15,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 7,500 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 32,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 49,245 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 27,705 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 16,000 | — | deriv |
| 22 Mar 2024 | OTHER | CymaBay Therapeutics, Inc. | 14,010 | — | deriv |
| 19 Feb 2024 | GRANT_AWARD | Locust Walk Acquisition Corp. | 2,000 | 0.00 USD | deriv |
| 14 Feb 2024 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 5,828 | — | |
| 24 Jan 2024 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 14,010 | 0.00 USD | deriv |
| 09 Sept 2023 | GRANT_AWARD | Locust Walk Acquisition Corp. | 40,000 | 0.00 USD | deriv |
| 19 May 2023 | EXERCISE | PhaseBio Pharmaceuticals Inc | 3,750 | — | |
| 19 May 2023 | EXERCISE | PhaseBio Pharmaceuticals Inc | 3,750 | 0.00 USD | deriv |
| 25 Jan 2023 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 17,500 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,750 | 0.00 USD | deriv |
| 07 Mar 2022 | OTHER | ZOGENIX, INC. | 22,000 | — | deriv |
| 07 Mar 2022 | OTHER | ZOGENIX, INC. | 20,000 | — | deriv |
| 25 Jan 2022 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 67,000 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 08 Oct 2021 | OTHER | CERO THERAPEUTICS HOLDINGS, INC. | 17,500 | — | deriv |